| Innovation Title | Categories | Lead Inventor | |
|---|---|---|---|
|
Arylnapthalene Vacuolar-ATPase Inhibitors
2018-DAVI-68178 |
Davisson, Vincent Jo | ||
|
Peptoid Cancer Drugs Targeting PCNA Designed via a Novel in Silico/In Vitro Pipeline
2016-DAVI-67362 |
Davisson, Vincent Jo | ||
|
Dr. V. Jo Davisson is a Professor of Medicinal Chemistry and Molecular Pharmacology at Purdue University. Dr. Davisson earned a B.A. from Wittenberg University, M.S. from Indiana University School of Medicine, and Ph.D. from the University of Utah. He also completed his postdoc at the University of California at San Francisco. His research focuses on medicinal chemistry and cellular pharmacology of natural product drugs; chemical, nanoscale, and microscale tools for analysis of biological systems; and protein-ligand and protein-protein dynamics. For additional information, visit Dr. Davisson's Purdue website: https://www.mcmp.purdue.edu/directory/davisson |
|
